Terms: = Sarcomas AND TRA
11 results:
1. Risk Factors for Treatment-Related Amenorrhea in Female Survivors of Childhood and Adolescent Cancer: 10-Year Experiences at Oncofertility Clinic in Korean Tertiary Center.
Park SJ; Choi JY; Kang HJ; Lee YJ; Lee YA; Han JY; Kim SW; Kim H; Ku SY
J Adolesc Young Adult Oncol; 2024 Feb; 13(1):162-169. PubMed ID: 38064519
[No Abstract] [Full Text] [Related]
2. Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for sarcomas.
Yeagley M; Chobrutskiy BI; Gozlan EC; Medikonda N; Patel DN; Falasiri S; Callahan BM; Huda T; Blanck G
Pediatr Hematol Oncol; 2021 Apr; 38(3):251-264. PubMed ID: 33616477
[TBL] [Abstract] [Full Text] [Related]
3. A phase I study investigation of metabolism, and disposition of [
Liu Y; Liu L; Liu L; Wang T; Guo L; Wang Y; Gao Z; Shu Y
Cancer Chemother Pharmacol; 2020 May; 85(5):907-915. PubMed ID: 32266457
[TBL] [Abstract] [Full Text] [Related]
4. Elimination of Osteosarcoma by Necroptosis with Graphene Oxide-Associated Anti-HER2 Antibodies.
Xiao H; Jensen PE; Chen X
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491952
[TBL] [Abstract] [Full Text] [Related]
5. A patient-derived orthotopic xenograft (PDOX) nude-mouse model precisely identifies effective and ineffective therapies for recurrent leiomyosarcoma.
Zhang Z; Hu K; Kiyuna T; Miyake K; Kawaguchi K; Igarashi K; Nelson SD; Li Y; Singh SR; Hoffman RM
Pharmacol Res; 2019 Apr; 142():169-175. PubMed ID: 30807865
[TBL] [Abstract] [Full Text] [Related]
6. Association of anti-HER2 antibody with graphene oxide for curative treatment of osteosarcoma.
Li L; Luo C; Song Z; Reyes-Vargas E; Clayton F; Huang J; Jensen P; Chen X
Nanomedicine; 2018 Feb; 14(2):581-593. PubMed ID: 29170110
[TBL] [Abstract] [Full Text] [Related]
7. Prone transradial Catheterization for Combined Single-Session transarterial Embolization and Percutaneous Posterior Approach Cryoablation of Solid Neoplasms.
Chick JFB; Branach C; Majdalany BS; Matthew Meadows J; Murrey DA; Saad WA; Khaja MS; Cooper KJ; Osher ML; Srinivasa RN
Cardiovasc Intervent Radiol; 2017 Jul; 40(7):1026-1032. PubMed ID: 27921153
[TBL] [Abstract] [Full Text] [Related]
8. Heterogeneity of osteosarcoma cell lines led to variable responses in reprogramming.
Choong PF; Teh HX; Teoh HK; Ong HK; Choo KB; Sugii S; Cheong SK; Kamarul T
Int J Med Sci; 2014; 11(11):1154-60. PubMed ID: 25170299
[TBL] [Abstract] [Full Text] [Related]
9. Expression and intracellular localization of ACA and tra-1-81 in smooth muscle cell tumors.
Sukhikh GT; Becker-Kojić Z; Kogan EA; Demura TA; Faizullina NM; Nizyaeva NV; Schott A; Ureña-Peralta JJ; Askol'skaya SI; Popov YV
Bull Exp Biol Med; 2013 Aug; 155(4):530-5. PubMed ID: 24143384
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids.
Brodowicz T; Wiltschke C; Kandioler-Eckersberger D; Grunt TW; Rudas M; Schneider SM; Hejna M; Budinsky A; Zielinski CC
Br J Cancer; 1999 Jul; 80(9):1350-8. PubMed ID: 10424735
[TBL] [Abstract] [Full Text] [Related]
11. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
[TBL] [Abstract] [Full Text] [Related]